Table 1b.
Patient groups
| Group | Definition | Sex |
Age (years) | Adenoma size (mm) | Synchronous adenomas | Recurrence-free timea | |
|---|---|---|---|---|---|---|---|
| Male | Female | ||||||
| A (n = 8) | No carcinoma and no adenoma recurrence | 4 | 4 | 71.5 (57–82) | 14.1 (1–60) | 1.5 (2–4) | 78.5 months (6–117) |
| B (n = 10) | No carcinoma but adenoma recurrence | 4 | 6 | 68.8 (59–82) | 24.5 (2–140) | 1.5 (2–5) | 21.3 months (3–48) |
| C (n = 18) | No carcinoma | 8 | 10 | 70 (57–82) | 18 | 1.5 | 46.7 months (3 –117) |
| D (n = 9) | Synchronous carcinoma but no adenoma recurrence | 4 | 5 | 69.8 (61–85) | 9.9 (2–20) | 2.3 (2–5) | 77.2 months (3–96) |
| E (n = 14) | Synchronous carcinoma and adenoma recurrence | 8 | 6 | 68.1 (44–78) | 24.9 (3–70) | 1.3 (2–5) | 18.4 months (7–44) |
| F (n = 23) | Synchronous carcinoma | 12 | 11 | 68.8 (44–85) | 19 | 1.7 | 41.4 months (3–96) |
a
Diagnoses of adenoma and/or carcinoma were considered as recurrence.